Unity Biotechnology Inc. (UBX) Fell -5.02% or -0.46 To Price $8.7 On Tuesday


Unity Biotechnology Inc. (UBX) fell -5.02% or -0.46 to $8.7. It is about 56696 shares traded, which is 39.45% compare to the average total volume 143725. The market cap of UBX is $372.86 million. The year to date change is -50.04%. The 52 week price range is from $8.54 to $24.56. Price of UBX have changed -10.37% during last week. It have changed -19.08% over last month, -37.60% over last 3 months, -49.64% over last 6 months and -44.98% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for UBX is 12.49. It is 43.56% above current price. The 200-day Moving Averages for UBX is 14.16. It is 62.76% above current price. The 52-week High is 24.56. It is 182.30% from the current price. The 52-week Low is 8.54. It is -1.84% from current price.

There are some statistics of UBX. It is has market cap $372.86 million. The share outstanding is 42.86 million. The average volume is 143725. The percent of top 15 Institution holding is 62.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of UBX is -196.95%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of UBX is -53.92%.


Tags:

Share this post